Mestastop Solutions have signed a memorandum of understanding with Syngene to provide its proprietary platform for metastasis discovery on a non-exclusive basis to Syngene clients, as per certain terms and
News
Jun 10, 2022
Nov 21, 2024
Nov 20, 2024
